About: Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1996 (uk) article scientifique publié en 1996 (fr) im Februar 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1996 (ast) artikull shkencor i botuar më 01 shkurt 1996 (sq) scientific article published on 01 February 1996 (en)
publication date	wds:Q70892397-C572B1D4-AA83-41A8-AF65-1E4AD632060E
publication date	1996-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70892397-58FF9923-50CD-42DF-8747-5A6781AE540B
language of work or name	English
author name string	wds:Q70892397-196092EB-B27D-46D7-AD8C-34BD09DE181D wds:Q70892397-264845F8-0948-4958-9615-F2D48894D085 wds:Q70892397-91F05DB1-4842-4552-B2F6-F9D64465A8D0 wds:Q70892397-97AAB9A0-D9C7-41A3-8013-5606C2A05D36
author name string	A Hinke T Otto G Lümmen S Möllhoff
rdfs:label	Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma (en) Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma (nl) Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma (sq)
skos:prefLabel	Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma (en) Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma (nl) Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma (sq)
name	Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma (en) Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma (nl) Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma (sq)
author	wds:Q70892397-370178FD-D404-4B71-8E2A-8A053940FC4C wds:Q70892397-A45E86D4-019F-4122-ACC3-7FBBD51F83F6
author	Mark Goepel Herbert Rübben
title	wds:Q70892397-A7BEA975-653F-4785-AADE-48DA70BF7B3E
title	Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma (en)
page(s)	wds:Q70892397-53711686-75DA-4E86-ABA5-620EF689230C
page(s)	455-458
instance of	wds:Q70892397-1D08A46C-D8C3-40B3-B28D-76DD9B18DB5D
instance of	scholarly article
main subject	wds:Q70892397-836CD693-7872-40E1-8FEF-CD32E0783840 wds:Q70892397-AEEC2B2E-160F-4F00-904D-06EDCFE80B58
main subject	renal cell carcinoma metastatic renal cell carcinoma
PubMed ID	wds:Q70892397-DCA5EF35-3A91-46E7-949D-5E1881EB8652
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8558634
PubMed ID	8558634
published in	wds:Q70892397-3E2DE144-6A12-491A-B672-C60F1C7FB108
published in	Journal of Urology
issue	wds:Q70892397-ACA4A9F7-DA4B-4689-8499-B53BC691D344
volume	wds:Q70892397-E4787C63-FBB4-4DAE-BD9D-FF3DCA9D6BCE
issue	2
volume	155
DOI	wds:Q70892397-0E45C8B0-AEB2-4B86-A891-46E1A3920C2E
DOI	http://dx.doi.org/10.1016/S0022-5347(01)66417-6
DOI	10.1016/S0022-5347(01)66417-6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70892397
is cites work of	Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial Immunotherapy for advanced renal cell cancer Immunotherapy for advanced renal cell cancer Immunotherapy for advanced renal cell cancer. Current status of cytokine therapy in management of patients with metastatic renal cell carcinoma Interleukin-2 in the treatment of unresectable or metastatic renal cell cancer: a systematic review and practice guideline. Relevance of the immune system in human urological malignancies: prospective for future clinical treatments [Inhaled immunotherapy for pulmonary metastases of renal cell cancer] Immunotherapy for metastatic renal cell carcinoma
is cites work of	wds:Q36710382-8321252F-9149-4AD4-B25D-2F91E30D687A wds:Q40857084-8D0A305D-D097-4D09-A331-56B31851404A wds:Q79928792-95545C05-2E29-45EC-AA91-D75EB00FF7CD wds:Q24187300-8D490BC6-94F7-424C-BF06-CC72D73297D1 wds:Q34583699-AA29A776-D4DC-4F13-8352-CDB13A89B54D wds:Q30234458-06DC12D1-E7E5-42CD-A65B-C6716652459E wds:Q30887373-E506D28B-B370-485E-80DE-78827AB1788E wds:Q24246777-458B5835-C87B-47DA-929D-B1FF32E6206B wds:Q37187448-47C09B8E-2A41-42F8-B202-CE856C880BE5

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software